An update on genetic aberrations in T-cell neoplasms

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• T-cell neoplasms, encompassing leukaemias and lymphomas, are highly heterogeneous and constitute 10-15% of lymphoid neoplasms.
• Understanding T-cell neoplasms has historically lagged behind B-cell neoplasms due to their rarity.

Purpose of the Study:

• To provide an overview of molecular abnormalities in various T-cell leukaemias and lymphomas.
• To highlight how recent advances elucidate pathogenetic mechanisms.
• To discuss the impact on diagnostics, prognostication, and therapeutics.

Main Methods:

• Review of gene expression profiling.
• Analysis of mutation profiling.
• Integration of high-throughput methods in understanding T-cell differentiation.

Main Results:

• Elucidation of pathogenetic mechanisms underlying T-cell leukaemias and lymphomas.
• Identification of numerous molecular abnormalities across different T-cell neoplasm subtypes.
• Refinement of diagnostic criteria, as reflected in the WHO classification.

Conclusions:

• Advances in molecular profiling have significantly improved the understanding of T-cell neoplasms.
• This knowledge is crucial for refining diagnostics and improving prognostication.
• Novel therapeutic targets are being identified, paving the way for better patient outcomes.